Literature DB >> 8970980

E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element.

S L Chen1, Y K Lin, L Y Li, Y P Tsao, H Y Lo, W B Wang, T C Tsai.   

Abstract

Human papillomavirus type 11 (HPV-11) and HPV-16 contain an E5 gene that can induce c-fos gene expression in mouse fibroblasts. This study investigated the human c-fos promoter characteristics by mapping the c-fos promoter sequence with several deletion and point mutants that confer responsiveness to E5 of HPV-11 or HPV-16. The mutant studies show that NF1 binding sequences within the c-fos promoter were crucial for the induction of the c-fos gene by E5, and the gel shift assay study suggested that E5 of both HPV-11 and HPV-16 is associated, perhaps indirectly, with this NF1 element in the transactivation of the human c-fos promoter. Using an inducible system, we demonstrate that increased induction of the HPV-11 E5 gene in cells led to increased transactivation of the NF1 element. In addition, the transactivating activity of a series of HPV-11 E5 mutants on the NF1 element had a strong correlation with their respective transforming activities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970980      PMCID: PMC190948     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Protein-protein interactions between adenovirus DNA polymerase and nuclear factor I mediate formation of the DNA replication preinitiation complex.

Authors:  M Chen; N Mermod; M S Horwitz
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

2.  Demonstration in living cells of an intragenic negative regulatory element within the rodent c-fos gene.

Authors:  N J Lamb; A Fernandez; N Tourkine; P Jeanteur; J M Blanchard
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

3.  The adenovirus EIIA enhancer. Analysis of regulatory sequences and changes in binding activity of ATF and EIIF following adenovirus infection.

Authors:  M R Loeken; J Brady
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

4.  The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain.

Authors:  N Mermod; E A O'Neill; T J Kelly; R Tjian
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

5.  Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.

Authors:  T Chong; W K Chan; H U Bernard
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

6.  Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells.

Authors:  S L Chen; P Mounts
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

7.  An AP1-binding site in the c-fos gene can mediate induction by epidermal growth factor and 12-O-tetradecanoyl phorbol-13-acetate.

Authors:  T M Fisch; R Prywes; R G Roeder
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

8.  Amino-terminal domain of NF1 binds to DNA as a dimer and activates adenovirus DNA replication.

Authors:  F Gounari; R De Francesco; J Schmitt; P van der Vliet; R Cortese; H Stunnenberg
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

9.  Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene.

Authors:  L Hennighausen; B Fleckenstein
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

10.  High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter.

Authors:  Y Shaul; R Ben-Levy; T De-Medina
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  7 in total

1.  Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses.

Authors:  Zigui Chen; Masanori Terai; Leiping Fu; Rolando Herrero; Rob DeSalle; Robert D Burk
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.

Authors:  Yi-Fang Chen; Chih-Wei Lin; Yeou-Ping Tsao; Show-Li Chen
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 3.  The E5 proteins.

Authors:  Daniel DiMaio; Lisa M Petti
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

Review 4.  Papillomavirus E5: the smallest oncoprotein with many functions.

Authors:  Aldo Venuti; Francesca Paolini; Lubna Nasir; Annunziata Corteggio; Sante Roperto; Maria S Campo; Giuseppe Borzacchiello
Journal:  Mol Cancer       Date:  2011-11-11       Impact factor: 27.401

5.  Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts.

Authors:  Rahul Nath; Christine A Mant; Barbara Kell; John Cason; Jon M Bible
Journal:  Cancer Cell Int       Date:  2006-08-09       Impact factor: 5.722

6.  Glycogene expression profiles from a HaCaT cell line stably transfected with HPV16 E5 oncogene.

Authors:  Denisse Cisneros-Ramírez; Ygnacio Martínez-Laguna; Patricia Martínez-Morales; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suárez; Gerardo Santos-López; Julio Reyes-Leyva; Verónica Vallejo-Ruiz
Journal:  Mol Med Rep       Date:  2020-10-23       Impact factor: 2.952

Review 7.  The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis.

Authors:  Om Basukala; Lawrence Banks
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.